CaixaBank, S.A.’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q3 | $56.8M | Buy |
74,906
+2,654
| +4% | +$2.01M | 0.25% | 81 |
|
|
2026
Q2 | $45.1M | Sell |
72,252
-25,985
| -26% | -$17.7M | 0.21% | 89 |
|
|
2026
Q1 | $75.9M | Buy |
98,237
+13,742
| +16% | +$10.5M | 0.41% | 57 |
|
|
2025
Q4 | $65.2M | Sell |
84,495
-15,372
| -15% | -$10.4M | 0.33% | 63 |
|
|
2025
Q3 | $56.2M | Sell |
99,867
-17,596
| -15% | -$9.9M | 0.28% | 66 |
|
|
2025
Q2 | $61.7M | Sell |
117,463
-72,752
| -38% | -$40.6M | 0.32% | 64 |
|
|
2025
Q1 | $121M | Sell |
190,215
-35,594
| -16% | -$24.5M | 0.7% | 41 |
|
|
2024
Q4 | $161M | Buy |
225,809
+46,475
| +26% | +$39M | 0.85% | 32 |
|
|
2024
Q3 | $189M | Sell |
179,334
-14,821
| -8% | -$16.5M | 1.03% | 25 |
|
|
2024
Q2 | $204M | Buy |
194,155
+1,451
| +0.8% | +$1.41M | 1.16% | 18 |
|
|
2024
Q1 | $185M | Buy |
192,704
+16,959
| +10% | +$16.1M | 1.1% | 23 |
|
|
2023
Q4 | $154M | Buy |
175,745
+804
| +0.5% | +$662K | 1.06% | 30 |
|
|
2023
Q3 | $144M | Sell |
174,941
-16,410
| -9% | -$12.9M | 1.11% | 28 |
|
|
2023
Q2 | $137M | Buy |
191,351
+1,025
| +0.5% | +$790K | 1.02% | 31 |
|
|
2023
Q1 | $156M | Sell |
190,326
-9,388
| -5% | -$7.08M | 1.26% | 24 |
|
|
2022
Q4 | $144M | Buy |
199,714
+44,345
| +29% | +$32.7M | 1.2% | 24 |
|
|
2022
Q3 | $107M | Sell |
155,369
-41,876
| -21% | -$26.4M | 0.94% | 30 |
|
|
2022
Q2 | $117M | Buy |
197,245
+34,042
| +21% | +$22.1M | 1.05% | 27 |
|
|
2022
Q1 | $114M | Buy |
163,203
+38,467
| +31% | +$24.3M | 0.93% | 28 |
|
|
2021
Q4 | $78.8M | Buy |
124,736
+25,651
| +26% | +$15.8M | 0.64% | 40 |
|
|
2021
Q3 | $60M | Buy |
99,085
+40,090
| +68% | +$24.9M | 0.54% | 47 |
|
|
2021
Q2 | $33M | Buy |
58,995
+45,089
| +324% | +$22.8M | 0.3% | 69 |
|
|
2021
Q1 | $6.58M | Buy |
13,906
+13,663
| +5,623% | +$6.65M | 0.07% | 202 |
|
|
2020
Q4 | $117K | Buy |
+243
| New | +$131K | ﹤0.01% | 407 |
|
|
2019
Q3 | – | Sell |
-25,801
| Closed | -$8.08M | – | 369 |
|
|
2019
Q2 | $8.08M | Sell |
25,801
-1,408
| -5% | -$469K | 0.18% | 171 |
|
|
2019
Q1 | $11.2M | Buy |
27,209
+24,387
| +864% | +$10M | 0.26% | 110 |
|
|
2018
Q4 | $1.02M | Sell |
2,822
-1,016
| -26% | -$372K | 0.03% | 202 |
|
|
2018
Q3 | $1.55M | Sell |
3,838
-33,172
| -90% | -$12.6M | 0.04% | 196 |
|
|
2018
Q2 | $12.8M | Sell |
37,010
-28,760
| -44% | -$8.99M | 0.41% | 54 |
|
|
2018
Q1 | $22.6M | Buy |
+65,770
| New | +$22.9M | 0.76% | 28 |
|
Other funds holding REGN
CaixaBank, S.A.'s REGN Position: Q3 2026 in Review
CaixaBank, S.A. increased its Regeneron Pharmaceuticals (REGN) stake by 3.7% in Q3 2026, buying an estimated $2.01M and bringing the position to 74,906 shares worth $56.8M. The position accounts for 0.25% of the portfolio, ranked #81.
CaixaBank, S.A. first reported a position in REGN in Q1 2018 and has held it in 30 quarters since. The position peaked at $204M in Q2 2024. 1,427 funds tracked by Wall St. Rank hold REGN as of Q3 2026.
- CaixaBank, S.A. held 74,906 shares of Regeneron Pharmaceuticals worth $56.8M as of Q3 2026.
- CaixaBank, S.A. bought 2,654 Regeneron Pharmaceuticals shares in Q3 2026, an estimated $2.01M.
- Regeneron Pharmaceuticals made up 0.25% of CaixaBank, S.A.'s portfolio in Q3 2026, its #81 holding.
- CaixaBank, S.A. first reported a position in Regeneron Pharmaceuticals in Q1 2018 and has held it in 30 quarters since.
- CaixaBank, S.A.'s Regeneron Pharmaceuticals position peaked at $204M in Q2 2024.
- 1,427 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q3 2026.
Based on CaixaBank, S.A.'s 13F filing for Q3 2026, filed 16 Nov 2026.